ProCE Banner Activity

ROSE2: Phase II Trial of Obicetrapib + Ezetimibe as an Adjunct to High-Intensity Statin Therapy

Capsule Summary
Conference Coverage
Slideset

Downloadable deck reviewing key takeaways from the ROSE2 trial.

Released: June 08, 2023

Share

Faculty

Payal Kohli

Payal Kohli, MD, FACC

Associate Adjunct Professor in Cardiology Division, Department of Medicine, Duke University
Associate Clinical Professor of Medicine, University of Colorado Anshutz
Founder and Medical Director, Cherry Creek Heart
On-Air Medical Expert, Tegna Broadcasting
Aurora, Colorado

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics